Skip to main content
OpenTrials
Completed

NCT Number: NCT01455727

Pharmaceutical Care of Ambulatory Elderly Diabetes Patients

This trial will try to perform pharmaceutical care on ambulatory elderly diabetes patients. To provide appropriate diabetes education administration, identify and resolve drug-related problems, assess the appropriateness of their medications, establish the mechanism of medication consultations. Each patient will be assessed by the MMSE(Mini-Mental State Examination) and GDS(Geriatric Depression Scale). The effectiveness of pharmacist's intervention will be assessed by lab data and some questionnaires.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

65 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nantou Hospital

Nantou City, 540, Taiwan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 65 years or older
  • A1c greater than or equal to 9.0

Exclusion criteria

  • Not expected to live for the duration of the study
  • Unwillingness to participate and attend pharmacist visits
  • Unwillingness to participate the questionnaires(MMSE, GDS)

Treatment and study plan

Pharmaceutical care

Other

The Pharmacist provided Pharmaceutical care on the ambulatory elderly Diabetes patients, provided recommendation to the physician and reffered the patients to other diabetes-care-team members, including the CDEs and dietitians.

Usual Care

Other

Control patients received usual care directed by their physician.

Primary outcomes

  1. Hgb A1c change

    Time frame: 12 month

    baseline, second measurement during 3 to 6 month after baseline, and the last measurement during 9 to 12 month after baseline

Secondary outcomes

  1. Mini-Mental State Examination(MMSE) Score change

    Time frame: 1 year

    baseline and the second test was performed after 3 month.

  2. Taiwan Geriatric Depression Scale(GDS) Score change

    Time frame: 1 year

    baseline and the second test was performed after 3 month.

Sponsors and collaborators

Lead sponsor

Nantou Hospital

Other Gov

Registry information

Important dates

Study start
2011
Primary completion
2012
First posted
Oct 20, 2011
Registry last updated
Sep 17, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.